{"pmid":32475041,"title":"Potential role of Anti-IL-17 in COVID-19 treatment.","text":["Potential role of Anti-IL-17 in COVID-19 treatment.","Dermatol Ther","Ayhan, Erhan","Ozturk, Murat","An, Isa","Abdelmaksoud, Ayman","Arac, Esref","32475041"],"journal":"Dermatol Ther","authors":["Ayhan, Erhan","Ozturk, Murat","An, Isa","Abdelmaksoud, Ayman","Arac, Esref"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475041","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/dth.13715","keywords":["covid-19","covid-19 treatment, sars-cov-2","il-17","anti-il-17, il-17 inhibitors"],"topics":["Treatment"],"weight":1,"_version_":1668341932662718464,"score":9.490897,"similar":[{"pmid":32504739,"title":"Interleukin-17: a potential therapeutic target in COVID-19.","text":["Interleukin-17: a potential therapeutic target in COVID-19.","J Infect","Mendoza, Vicky M Montano","32504739"],"journal":"J Infect","authors":["Mendoza, Vicky M Montano"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504739","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jinf.2020.05.072","keywords":["covid-19","il-17","cytokine storm","immunomodulatory therapy","lung injury"],"topics":["Treatment"],"weight":1,"_version_":1668892488281096192,"score":69.25394},{"pmid":32339777,"pmcid":"PMC7175896","title":"May IL-17 have a role in COVID-19 infection?","text":["May IL-17 have a role in COVID-19 infection?","Med Hypotheses","Megna, Matteo","Napolitano, Maddalena","Fabbrocini, Gabriella","32339777"],"journal":"Med Hypotheses","authors":["Megna, Matteo","Napolitano, Maddalena","Fabbrocini, Gabriella"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339777","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109749","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138494189174787,"score":58.532917},{"pmid":32450087,"title":"ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19.","text":["ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19.","To-date, there has not been a clear signal suggesting that asthma or treatment with inhaled steroids are a risk factor for severe COVID-19 disease. We have therefore explored ACE2 receptor mRNA expression, and co-factors for Sars-CoV-2 infectivity (TMPRSS2 and furin) in bronchial brushes and biopsies from people with asthma and healthy controls, and looked for relationships between asthma severity, Th2- and IL-17 dependent gene signatures, and clinical demographics (age, sex). We have looked at a cohort of 356 research participants from previously described studies. The only significant association was a positive correlation between ACE2 and IL-17-dependent gene expression, and an inverse correlation between ACE2 and Th2-cytokine-dependent gene expression. These data suggest that differences in ACE2, TMPRSS2 and furin epithelial and airway gene expression are unlikely to confer enhanced COVID-19 pneumonia risk in patients with asthma across all treatment intensities and severity.","J Allergy Clin Immunol","Bradding, Peter","Richardson, Matthew","Hinks, Timothy S C","Howarth, Peter H","Choy, David F","Arron, Joseph R","Wenzel, Sally E","Siddiqui, Salman","32450087"],"abstract":["To-date, there has not been a clear signal suggesting that asthma or treatment with inhaled steroids are a risk factor for severe COVID-19 disease. We have therefore explored ACE2 receptor mRNA expression, and co-factors for Sars-CoV-2 infectivity (TMPRSS2 and furin) in bronchial brushes and biopsies from people with asthma and healthy controls, and looked for relationships between asthma severity, Th2- and IL-17 dependent gene signatures, and clinical demographics (age, sex). We have looked at a cohort of 356 research participants from previously described studies. The only significant association was a positive correlation between ACE2 and IL-17-dependent gene expression, and an inverse correlation between ACE2 and Th2-cytokine-dependent gene expression. These data suggest that differences in ACE2, TMPRSS2 and furin epithelial and airway gene expression are unlikely to confer enhanced COVID-19 pneumonia risk in patients with asthma across all treatment intensities and severity."],"journal":"J Allergy Clin Immunol","authors":["Bradding, Peter","Richardson, Matthew","Hinks, Timothy S C","Howarth, Peter H","Choy, David F","Arron, Joseph R","Wenzel, Sally E","Siddiqui, Salman"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32450087","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jaci.2020.05.013","keywords":["ace2","covid-19","il-17","tmprss2","th2","asthma","bronchial biopsy","bronchial brush","furin"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213999054848,"score":54.553974},{"pmid":32353597,"pmcid":"PMC7185017","title":"SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.","text":["SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.","The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection.","J Thorac Oncol","Cafarotti, Stefano","32353597"],"abstract":["The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection."],"journal":"J Thorac Oncol","authors":["Cafarotti, Stefano"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353597","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jtho.2020.04.015","locations":["Lung Cancer"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495654035458,"score":53.88298},{"pmid":32358580,"pmcid":"PMC7194244","title":"COVID-19: a case for inhibiting IL-17?","text":["COVID-19: a case for inhibiting IL-17?","Nat Rev Immunol","Pacha, Omar","Sallman, Mary Alice","Evans, Scott E","32358580"],"journal":"Nat Rev Immunol","authors":["Pacha, Omar","Sallman, Mary Alice","Evans, Scott E"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358580","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41577-020-0328-z","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495342608384,"score":47.79755}]}